Cargando…
A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia
Paediatric acute myeloid leukaemia (AML) is a heterogeneous disease characterised by genetics and morphology. The introduction of intensive chemotherapy treatments together with patient stratification and supportive therapy has resulted in a moderate improvement in patient prognosis. However, overal...
Autores principales: | Lappin, Katrina M., Davis, Lindsay, Matchett, Kyle B., Ge, Yubin, Mills, Ken I., Blayney, Jaine K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595190/ https://www.ncbi.nlm.nih.gov/pubmed/33116257 http://dx.doi.org/10.1038/s41598-020-75453-3 |
Ejemplares similares
-
Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia
por: Cairns, Lauren V., et al.
Publicado: (2021) -
Combination Therapies Targeting Apoptosis in Paediatric AML: Understanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics
por: Ali, Ahlam A., et al.
Publicado: (2023) -
Identification of Genes Whose Expression Overlaps Age Boundaries and Correlates with Risk Groups in Paediatric and Adult Acute Myeloid Leukaemia
por: Davis, Lindsay, et al.
Publicado: (2020) -
Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy
por: Hay, Jodie F., et al.
Publicado: (2017) -
Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia
por: Aung, Myint Myat Khine, et al.
Publicado: (2021)